RxDoctor Payments DataLook up a doctor →

James Grantham, MD

Interventional Cardiology · Kansas City, MONPI 1134185390

Payments from drug & device makers

$1,602,030in general payments, 2019–2025

Across 409 payments — averaging $3916.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1.4M
  • Siemens Medical Solutions USA, Inc.$109K
  • Asahi Intecc USA, Inc.$35K
  • Abbott$20K
  • Medtronic$14K
  • Teleflex LLC$11K
  • plus $23K from 9 others
$1,000in research payments, 2019–2025

Across 1 payment — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Asahi Intecc USA, Inc.$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,602,030 in reported general payments places this provider in the 95th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri

Medicare billing

Part B allowed, 2024
$167,687
Medicare patients
643
Services billed
1,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →